BTX-1188, a first-in-class dual degrader of GSPT1 and IKZF1/3, for treatment of acute myeloid leukemia (AML) and solid tumors.

Venclexta (venetoclax) - Roche, AbbVie

cytarabine - Generic mfg.

BTX-1188 - BioTheryX

CC-90009 - BMS

https://meetings.asco.org/abstracts-presentations/208224

Aparajita Hoskote Chourasia; Hannah Majeski; Angela Pasis; Paul Erdman; Ashwini Oke; David Hecht; David Lonergan; Frank Mercurio; Kyle Chan; Dung Luong Thai; Leah Fung

Apr 28, 2022